These experiments showed that administration of granulocyte (G)– or granulocyte–macrophage (GM)–colony-stimulating factor (CSF) rescued animals from H-ARS and reduced bacteremia in the nonhuman primate (NHP). This evidence concerns the gene CSF2 and bacterial infectious disease with sepsis.